Find a Specialist by Postal Code | Page 8 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Find a Specialist by Postal Code

This is a working list in progress of bone marrow failure specialists who are seeing new patients for treatment or consultation.

It’s important for patients to seek consultation with physicians who have experience working with bone marrow failure disease. We’ve developed this interactive map of physician specialists in bone marrow failure disease who have worked with the Aplastic Anemia and MDS International Foundation in a significant way as speakers, writers, editors, and/or advisors. This map will allow you to search for physicians in your area by location using the zoom-in feature, by zip code, or by disease area utilizing the dropdowns provided below.

Please note:

  • This list is not comprehensive and there may be specialists in your area who have not yet been included.
  • Physicians may move to another institution for various reasons and may no longer be at the location noted on this map.
  • The map will be updated as often as possible.

If you do not find a physician on this map, please contact our Patient Educator Leigh Clark at clark@aamds.org for assistance locating a specialist in your area.

Name Institution City State Country Disease Expertise
Steven Gore, M.D. Yale New Haven Hospital New Haven Connecticut United States
  • Myelodysplastic Syndromes (MDS)
Katherine Tarlock, MD Seattle Children's Hospital Seattle Washington United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Pediatric
Srinivasa Reddy Sanikommu, MD Levine Cancer Institute - Morehead Charlotte North Carolina United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Aziz Nazha, MD The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Geoffrey Uy, MD Siteman Cancer Center St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Aaron Gerds, MD, MS The Cleveland Clinic Taussig Cancer Institute Cleveland Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Christopher Cogle, MD University of Florida Health Cancer Center Gainesville Florida United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Uma Borate, MBBS The Ohio State University Comprehensive Cancer Center Columbus Ohio United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Shannon McCurdy, MD University of Pennsylvania Philadelphia Pennsylvania United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Peter Westervelt, MD, PhD Siteman Cancer Center St. Louis Missouri United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Krishna Gundabolu, MBBS Fred and Pamela Buffett Cancer Center Omaha Nebraska United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Gabrielle Meyers, MD OHSU Hospital Portland Oregon United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
David Steensma, MD, FACP Dana-Farber Cancer Institute Boston Massachusetts United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Brian Shaffer, MD Memorial Slone Kettering Cancer Center New York, NY New York United States
  • Chronic Lymphocytic Leukemia (CLL)
Ryan J. Mattison, MD University of Wisconsin Health Madison Wisconsin United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Chronic Lymphocytic Leukemia (CLL)
  • Chronic Myelomonocytic Leukaemia (CMML)
  • Graft Versus Host Disease (GVHD)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pure Red Cell Aplasia (PRCA)
Veronica Dioverti, MD Johns Hopkins University School of Medicine Baltimore Maryland United States
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Tapan M. Kadia, MD MD Anderson Cancer Center Houston Texas United States
  • Acute Myeloid Leukemia (AML)
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
Daniel Pollyea, MD, MS University of Colorado School of Medicine, Blood Disorders Clinic Aurora Colorado United States
  • Acute Myeloid Leukemia (AML)
  • Myeloproliferative Neoplasms (MPN)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
Casey O'Connell, MD Keck Medicine of USC Los Angeles California United States
  • Myelodysplastic Syndromes (MDS)
  • Myeloproliferative Neoplasms (MPN)
Akiko Shimamura, MD Dana-Farber/Boston Children’s Cancer and Blood Disorders Center Boston Massachusetts United States
  • Aplastic Anemia
  • Myelodysplastic Syndromes (MDS)
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • Pediatric